CUAMC
NAUT icon

China Universal Asset Management Company’s Nautilus Biotechnolgy NAUT Stock Holding History

China Universal Asset Management Company’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,121
Closed -$68.7K – 515
2024
Q3 		$68.7K Buy
24,121
+9,404
+64% +$24.3K 0.01% 377
2024
Q2 		$34.4K Sell
14,717
-9,359
-39% -$24.4K ﹤0.01% 376
2024
Q1 		$70.8K Buy
24,076
+9,624
+67% +$27.3K 0.01% 394
2023
Q4 		$43.2K Buy
14,452
+11,248
+351% +$32.2K 0.01% 382
2023
Q3 		$10.1K Buy
3,204
+1,567
+96% +$5.1K ﹤0.01% 344
2023
Q2 		$6.33K Sell
1,637
-55
-3% -$158 ﹤0.01% 348
2023
Q1 		$4.69K Buy
1,692
+425
+34% +$891 ﹤0.01% 370
2022
Q4 		$2.28K Buy
1,267
+99
+8% +$191 ﹤0.01% 362
2022
Q3 		$2K Buy
+1,168
New +$2.94K ﹤0.01% 353

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

China Universal Asset Management Company's NAUT Position: Q4 2024 in Review

China Universal Asset Management Company sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 24,121 shares — an estimated $68.7K sold.

China Universal Asset Management Company first reported a position in NAUT in Q3 2022 and held it in 9 quarters. The position peaked at $70.8K in Q1 2024. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

  • China Universal Asset Management Company reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
  • China Universal Asset Management Company sold 24,121 Nautilus Biotechnolgy shares in Q4 2024, an estimated $68.7K.
  • China Universal Asset Management Company first reported a position in Nautilus Biotechnolgy in Q3 2022 and held it in 9 quarters.
  • China Universal Asset Management Company's Nautilus Biotechnolgy position peaked at $70.8K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.